Can Elevated Pretreatment Serum Carcinoembryonic Antigen Levels Serve as a Potential Biomarker Guiding Adjuvant Chemotherapy in Rectal Cancer Patients With ypTis-3N0 After Neoadjuvant Radiotherapy and Surgery?

Can Elevated Pretreatment Serum Carcinoembryonic Antigen Levels Serve as a Potential Biomarker Guiding Adjuvant Chemotherapy in Rectal Cancer Patients With ypTis-3N0 After Neoadjuvant Radiotherapy and Surgery?

Survival benefit of adjuvant chemotherapy (ACT) remained controversial in patients with stage II/III rectal cancer (RC) who received neoadjuvant therapy and surgery. This study aimed to investigate the guiding role of elevated pretreatment serum carcinoembryonic antigen (CEA) levels for receiving AC...

Full description

Bibliographic Details
Main Authors: Chi Huang, Mingkun Jiang, Yan Li, Chaoyang Tang, Xiang Ma, Xiangkun Huan
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-08-01
Series:Frontiers in Oncology
Subjects:
neoadjuvant radiotherapy
rectal cancer
serum carcinoembryonic antigen
ypTis-3N0
surgery
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.705460/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.705460/full

Similar Items